JournalsHub
.online
Find My Journal
GW

Guomin Wang

Tongji University CN

ORCID 0000-0003-2707-7051
230
Publications
8,710
Citations
39
H-Index
102
i10-Index
1.92
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Suppression of immune regulatory cells with combined therapy of celecoxib and sunitinib in renal cell carcinoma OA

Qi Zhao, Jianming Guo, Guomin Wang, Y. Chu, Xiaoyi Hu - OncoTarget, 2016
Cited by 27 Semantic Scholar

Renal cell carcinoma may evade the immune system by converting CD4+Foxp3- T cells into CD4+CD25+Foxp3+ regulatory T cells: Role of tumor COX-2-derived PGE2. OA

Jinfeng Li, G. Feng, Jia Liu, R. Rong, Feifei Luo - Molecular Medicine Reports, 2010
Cited by 16 Semantic Scholar

The clinical application of COX-2 inhibitors may strengthen the sensitivity of renal cell carcinoma to immunotherapy.

Jinfeng Li, Guomin Wang, Y. Chu, R. Rong, T. Zhu - Medical Hypotheses, 2008
Cited by 3 Semantic Scholar

Research Topics

Bone Tissue Engineering Materials (17) Graphene and Nanomaterials Applications (15) Electrochemical sensors and biosensors (13) Renal cell carcinoma treatment (12) Plasma Applications and Diagnostics (11)

Affiliations

Tongji University
CN 2025 - 2022
Texas A&M Health Science Center
US 2009 - 2009
Academy of Medical Sciences
GB 2010 - 2010
Apple (Israel)
IL 2015 - 2015
Shanghai Medical College of Fudan University
CN 2019 - 2019

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now